Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer
Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation...
Carbone, David P.
2006-01-01 00:00:00
The maximally tolerated and recommended phase II paclitaxel dose delivered by protracted continuous infusion is 15 mg/m
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngJournal of Thoracic OncologyWolters Kluwer Healthhttp://www.deepdyve.com/lp/wolters-kluwer-health/phase-i-study-of-paclitaxel-given-by-seven-week-continuous-infusion-5sSwb3Dhfk
Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.